Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet

Association Between Visfatin and Hepatic Steatosis in the General Population During Long-Term Follow-Up

(2019) Katharina Johannsen et al.   HORMONE AND METABOLIC RESEARCH

Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

(2018) Zobair Younossi et al.   HEPATOLOGY

Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study

(2018) Yun Qiu et al.   ANNALS OF NUTRITION AND METABOLISM

SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress

(2017) Xiaobin Zheng et al.   HEPATOLOGY

Serum resistin positively correlates with serum lipids, but not with insulin resistance, in first-degree relatives of type-2 diabetes patients

(2017) Xiao-hong Niu et al.   MEDICINE

Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease

(2017) Flavia A Cimini et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Treating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a review of efficacy and safety

(2017) Elizabeth P. Mills et al.   Therapeutic Advances in Endocrinology and Metabolism

Effect of curcumin on visfatin and zinc-α2-glycoprotein in a rat model of non-alcoholic fatty liver disease

(2016) Changping Li et al.   Acta Cirurgica Brasileira

C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis

(2016) Khalidur Rahman et al.   LABORATORY INVESTIGATION

Pharmacological management of nonalcoholic fatty liver disease

(2016) Diana Barb et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease

(2016) Raika Jamali et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway

(2014) Young Mi Song et al.   Autophagy

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Obese Children

(2013) Lior Hecht et al.   Current Diabetes Reports

Characteristics and diagnosis of NAFLD/NASH

(2013) Etsuko Hashimoto et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hydrogen-1 MR Spectroscopy for Measurement and Diagnosis of Hepatic Steatosis

(2012) Patrick Georgoff et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

(2012) Naga Chalasani et al.   GASTROENTEROLOGY

Visfatin Levels in Nonalcoholic Fatty Liver Disease

(2012) Erdem Akbal et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

(2010) Nitika Arora Gupta et al.   HEPATOLOGY

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

(2010) Mustafa S. Ascha et al.   HEPATOLOGY

Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease

(2010) Tuva B. Dahl et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY